Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India

被引:2
作者
Mittal, Niti [1 ]
Gupta, Mahesh [1 ]
Singla, Mohit [1 ]
机构
[1] Postgrad Inst Med Sci, Rohtak, Haryana, India
关键词
Adverse reactions; causality; cutaneous; pharmacovigilance; preventability; TOXIC EPIDERMAL NECROLYSIS; CAUSATIVE AGENTS; JOHNSON SYNDROME; CLINICAL TYPES; INPATIENTS; PERIOD;
D O I
10.3109/15569527.2013.857678
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Context: Medication-related adverse events, apart from causing significant morbidity and mortality, increase the healthcare cost burden and lead to early treatment discontinuations. Objectives: Knowing the fact that cutaneous adverse drug reactions (cADRs) are most frequent, this study was conducted with an aim to describe their clinical profiles and preventive strategies. Methods: All adverse drug reaction (ADR) forms filled from January 2012 to January 2013 were scrutinised and forms with cADRs analysed and assessed for causality, preventability and severity. Results: Of 400 ADR forms, 109 included cADRs. Sixty-eight percent patients were males and mean +/- SD age was 35 +/- 18 years. Rash, Steven-Johnson syndrome and toxic epidermal necrolysis were the most common presentations. Most frequent culprit drugs included antibiotics and anti-inflammatory agents. Causality was probable or possible in majority. Ninety percent cases were "not preventable". Majority of the patients had mild to moderate reactions and recovered completely after medical management. Conclusions: Pharmacovigilance, with special attention to monitoring and reporting of cADRs must be encouraged. As major bulk of cADRs result from physician prescribed drugs, awareness on part of the physician can help in their timely detection and management, thereby restricting the associated damage.
引用
收藏
页码:289 / 293
页数:5
相关论文
共 32 条
[1]   Cutaneous adverse drug reaction profile in a tertiary care out patient setting in Eastern India [J].
Abanti, Saha ;
Kanti, Das Nilay ;
Avijit, Hazra ;
Chandra, Gharami Ramesh ;
Nath, Chowdhury Satyendra ;
Kanti, Datta Pijush .
INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (06) :792-797
[2]  
ALANKO K, 1989, ACTA DERM-VENEREOL, V69, P223
[3]   Adverse drug reaction monitoring in a secondary care hospital in South India [J].
Arulmani, R. ;
Rajendran, S. D. ;
Suresh, B. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 (02) :210-216
[4]   The prevalence of acute cutaneous drug reactions in a Scandinavian university hospital [J].
Borch, Jakob E. ;
Andersen, Klaus E. ;
Bindslev-Jensen, Carsten .
ACTA DERMATO-VENEREOLOGICA, 2006, 86 (06) :518-522
[5]   Acetaminophen-induced toxic epidermal necrolysis in a child [J].
Bygum, A ;
Gregersen, JW ;
Buus, SK .
PEDIATRIC DERMATOLOGY, 2004, 21 (03) :236-238
[6]   An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia [J].
Choon, Siew-Eng ;
Lai, Nai-Ming .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2012, 78 (06) :734-739
[7]   Sitagliptin-Associated Drug Allergy: Review of Spontaneous Adverse Event Reports [J].
Desai, Shrey ;
Brinker, Allen ;
Swann, Joslyn ;
Iyasu, Solomon .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (13) :1169-1171
[8]  
Devi K, 2005, Indian J Dermatol Venereol Leprol, V71, P325
[9]   A 6-month prospective survey of cutaneous drug reactions in a hospital setting [J].
Fiszenson-Albala, F ;
Auzerie, V ;
Mahe, E ;
Farinotti, R ;
Durand-Stocco, C ;
Crickx, B ;
Descamps, V .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (05) :1018-1022
[10]  
Halevi A, 2000, ANN PHARMACOTHER, V34, P32